{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:19:41Z","timestamp":1761581981401,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejrad.2020.109146","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T11:56:40Z","timestamp":1593777400000},"page":"109146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer"],"prefix":"10.1016","volume":"130","author":[{"given":"Dorothy Ibifuro","family":"Makanjuola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmohsen","family":"Alkushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Al Anazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejrad.2020.109146_bib0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2407-7-222","article-title":"Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience","volume":"7","author":"Elkum","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejrad.2020.109146_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.11604\/pamj.2014.19.35.2849","article-title":"Breast cancer in women younger than 30 years: prevalence rate and imaging findings in a symptomatic population","volume":"19","author":"Makanjuola","year":"2014","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.ejrad.2020.109146_bib0015","first-page":"1996","article-title":"Presence of a growth-stimulating factor in serum following primary tumor removal in mice","volume":"49","author":"Fisher","year":"1989","journal-title":"Cancer Res."},{"issue":"July 7","key":"10.1016\/j.ejrad.2020.109146_bib0020","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on locoregional disease in adjuvant breast and bowel project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"9938","key":"10.1016\/j.ejrad.2020.109146_bib0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"year":"2019","series-title":"Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Evaluated by Residual Cancer Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore. Precision Medicine and Imaging","author":"Steenbruggen","key":"10.1016\/j.ejrad.2020.109146_bib0030"},{"issue":"May 15","key":"10.1016\/j.ejrad.2020.109146_bib0035","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"March 6","key":"10.1016\/j.ejrad.2020.109146_bib0040","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.2002.20.6.1456","article-title":"Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel","volume":"20","author":"Smith","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2020.109146_bib0045","first-page":"GS2","volume":"79","author":"Spring","year":"2019","journal-title":"Cancer Res."},{"issue":"December","key":"10.1016\/j.ejrad.2020.109146_bib0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2016.09.034","article-title":"Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?","volume":"69","author":"Heil","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"August 8","key":"10.1016\/j.ejrad.2020.109146_bib0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.crad.2018.01.005","article-title":"The importance of histological assessment after neoadjuvant therapy and the need for standardisation","volume":"73","author":"Naidoo","year":"2018","journal-title":"Clin. Radiol."},{"issue":"February 3","key":"10.1016\/j.ejrad.2020.109146_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"November 22","key":"10.1016\/j.ejrad.2020.109146_bib0065","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902","volume":"19","author":"van der Hage","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.ejrad.2020.109146_bib0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","article-title":"Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18","author":"Wolmark","year":"2001","journal-title":"J Natl Cancer Inst Monogr."},{"issue":"February 2","key":"10.1016\/j.ejrad.2020.109146_bib0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.sla.0000197714.14318.6f","article-title":"Accuracy of physical examination, Ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy","volume":"243","author":"Chagpar","year":"2006","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejrad.2020.109146_bib0080","first-page":"87","article-title":"Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection","author":"Kim","year":"2014","journal-title":"BJR"},{"issue":"March 3","key":"10.1016\/j.ejrad.2020.109146_bib0085","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2214\/ajr.184.3.01840868","article-title":"Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer","volume":"184","author":"Yeh","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"issue":"November 5","key":"10.1016\/j.ejrad.2020.109146_bib0090","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2214\/ajr.179.5.1791193","article-title":"Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy","volume":"179","author":"Partridge","year":"2002","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2020.109146_bib0095","first-page":"132","article-title":"Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy","author":"Taourel","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"73","key":"10.1016\/j.ejrad.2020.109146_bib0100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.crad.2017.10.021","article-title":"Clinical role of breast MRI now and going forward","author":"Leithner","year":"2018","journal-title":"Clin. Radiol."},{"issue":"11","key":"10.1016\/j.ejrad.2020.109146_bib0105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1245\/s10434-006-9086-9","article-title":"Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy","volume":"13","author":"Peintinger","year":"2006","journal-title":"Ann. Surg. Oncol."},{"issue":"February","key":"10.1016\/j.ejrad.2020.109146_bib0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2214\/AJR.16.17223","article-title":"Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer","volume":"208","author":"Rauch","year":"2017","journal-title":"AJR"},{"issue":"April 4","key":"10.1016\/j.ejrad.2020.109146_bib0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.amjsurg.2009.03.012","article-title":"Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer","volume":"199","author":"Keune","year":"2010","journal-title":"Am. J. Surg."},{"issue":"1","key":"10.1016\/j.ejrad.2020.109146_bib0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12282-011-0311-4","article-title":"The detection of pCR after PSTby contrast-enhanced ultrasonography for breast cancer","volume":"20","author":"Fujisawa","year":"2013","journal-title":"Breast Cancer"},{"issue":"November 6","key":"10.1016\/j.ejrad.2020.109146_bib0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12282-014-0524-4","article-title":"Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG","volume":"22","author":"Kuroi","year":"2015","journal-title":"Breast Cancer"},{"issue":"May 15","key":"10.1016\/j.ejrad.2020.109146_bib0130","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2020.109146_bib0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ejso.2013.06.005","article-title":"Time to stop operating on breast cancer patients with pathologic complete response","volume":"39","author":"Rea","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2020.109146_bib0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13058-016-0684-6","article-title":"Selective elimination of breast cancer surgery in exceptional responders. Historic perspective and current trials","volume":"18","author":"Van La Parra","year":"2016","journal-title":"Breast Cancer Res."},{"year":"2003","series-title":"American College of Radiology Breast Imaging Reporting and Data System BI-RADS] Atlas","key":"10.1016\/j.ejrad.2020.109146_bib0145"},{"issue":"March 5","key":"10.1016\/j.ejrad.2020.109146_bib0150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2002.20.5.1304","article-title":"Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes","volume":"20","author":"Rouzier","year":"2002","journal-title":"J. Clin. Oncol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X20303351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X20303351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:18:39Z","timestamp":1759994319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X20303351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0720048X20303351"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2020.109146","relation":{},"ISSN":["0720-048X"],"issn-type":[{"type":"print","value":"0720-048X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2020.109146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109146"}}